248 related articles for article (PubMed ID: 24032592)
1. Studies on the inactivation of human parvovirus 4.
Baylis SA; Tuke PW; Miyagawa E; Blümel J
Transfusion; 2013 Oct; 53(10 Pt 2):2585-92. PubMed ID: 24032592
[TBL] [Abstract][Full Text] [Related]
2. Inactivation and neutralization of parvovirus B19 Genotype 3.
Blümel J; Rinckel LA; Lee DC; Roth NJ; Baylis SA
Transfusion; 2012 Jul; 52(7):1490-7. PubMed ID: 22339291
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses.
Mani B; Gerber M; Lieby P; Boschetti N; Kempf C; Ros C
Transfusion; 2007 Oct; 47(10):1765-74. PubMed ID: 17880601
[TBL] [Abstract][Full Text] [Related]
4. Different susceptibility of B19 virus and mice minute virus to low pH treatment.
Boschetti N; Niederhauser I; Kempf C; Stühler A; Löwer J; Blümel J
Transfusion; 2004 Jul; 44(7):1079-86. PubMed ID: 15225251
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentrates.
Berting A; Modrof J; Unger U; Gessner M; Klotz A; Poelsler G; Kreil TR
Transfusion; 2008 Jun; 48(6):1220-6. PubMed ID: 18410254
[TBL] [Abstract][Full Text] [Related]
6. Human parvovirus PARV4 in clotting factor VIII concentrates.
Fryer JF; Hubbard AR; Baylis SA
Vox Sang; 2007 Nov; 93(4):341-7. PubMed ID: 18070279
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new LightCycler reverse transcription-polymerase chain reaction infectivity assay for detection of human parvovirus B19 in dry-heat inactivation studies.
Prikhod'ko GG; Vasilyeva I; Reyes H; Wong S; Brown KE; Jameson T; Busby TF
Transfusion; 2005 Jun; 45(6):1011-9. PubMed ID: 15935001
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus uncoating in vitro reveals a mechanism of DNA release without capsid disassembly and striking differences in encapsidated DNA stability.
Ros C; Baltzer C; Mani B; Kempf C
Virology; 2006 Feb; 345(1):137-47. PubMed ID: 16242744
[TBL] [Abstract][Full Text] [Related]
9. Identification of human parvovirus 4 genotypes 1 and 2 in Chinese source plasma pools.
Jia J; Zhong Y; Zhang H; Yuan D; Ma L; Wang D; Zhang J; Ma Y
J Med Virol; 2021 Aug; 93(8):4780-4785. PubMed ID: 33200412
[TBL] [Abstract][Full Text] [Related]
10. Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V).
Corcioli F; Zakrzewska K; Fanci R; De Giorgi V; Innocenti M; Rotellini M; Di Lollo S; Azzi A
Virol J; 2010 Oct; 7():272. PubMed ID: 20950445
[TBL] [Abstract][Full Text] [Related]
11. Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT.
Rahiala J; Koskenvuo M; Norja P; Meriluoto M; Toppinen M; Lahtinen A; Väisänen E; Waris M; Vuorinen T; Saarinen-Pihkala U; Lappalainen M; Allander T; Ruuskanen O; Hedman K; Söderlund-Venermo M; Vettenranta K
Bone Marrow Transplant; 2013 Oct; 48(10):1308-12. PubMed ID: 23686097
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates.
Modrow S; Wenzel JJ; Schimanski S; Schwarzbeck J; Rothe U; Oldenburg J; Jilg W; Eis-Hübinger AM
Vox Sang; 2011 May; 100(4):351-8. PubMed ID: 21133933
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous detection and differentiation of human parvovirus B19 and human parvovirus 4 by an internally controlled multiplex quantitative real-time PCR.
Jia J; Zhong Y; Guo Y; Huangfu C; Zhao X; Fang C; Fan R; Ma Y; Zhang J
Mol Cell Probes; 2017 Dec; 36():50-57. PubMed ID: 28863892
[TBL] [Abstract][Full Text] [Related]
14. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.
Sakata H; Matsubayashi K; Ihara H; Sato S; Kato T; Wakisaka A; Tadokoro K; Yu MY; Baylis SA; Ikeda H; Takamoto S
Transfusion; 2013 Oct; 53(10 Pt 2):2556-66. PubMed ID: 23145866
[TBL] [Abstract][Full Text] [Related]
15. Update of the human parvovirus B19 biology.
Servant-Delmas A; Morinet F
Transfus Clin Biol; 2016 Feb; 23(1):5-12. PubMed ID: 26778837
[TBL] [Abstract][Full Text] [Related]
16. Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals.
Fryer JF; Delwart E; Hecht FM; Bernardin F; Jones MS; Shah N; Baylis SA
Transfusion; 2007 Jun; 47(6):1054-61. PubMed ID: 17524097
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of parvovirus B19 by liquid heating incorporated in the manufacturing process of human intravenous immunoglobulin preparations.
Yunoki M; Urayama T; Tsujikawa M; Sasaki Y; Abe S; Takechi K; Ikuta K
Br J Haematol; 2005 Feb; 128(3):401-4. PubMed ID: 15667545
[TBL] [Abstract][Full Text] [Related]
18. Variability of parvovirus B19 to inactivation by liquid heating in plasma products.
Hattori S; Yunoki M; Tsujikawa M; Urayama T; Tachibana Y; Yamamoto I; Yamamoto S; Ikuta K
Vox Sang; 2007 Feb; 92(2):121-4. PubMed ID: 17298573
[TBL] [Abstract][Full Text] [Related]
19. Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples.
Maple PA; Beard S; Parry RP; Brown KE
Transfusion; 2013 Oct; 53(10 Pt 2):2575-84. PubMed ID: 23721256
[TBL] [Abstract][Full Text] [Related]
20. Multicenter evaluation of a commercial multiplex polymerase chain reaction test for screening plasma donations for parvovirus B19 DNA and hepatitis A virus RNA.
Koppelman MH; Cuijpers HT; Wessberg S; Valkeajärvi A; Pichl L; Schottstedt V; Saldanha J
Transfusion; 2012 Jul; 52(7):1498-508. PubMed ID: 22587637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
